SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-163498
Filing Date
2024-06-18
Accepted
2024-06-18 17:07:02
Documents
21
Period of Report
2024-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d854991d8k.htm   iXBRL 8-K 37012
2 EX-1.1 d854991dex11.htm EX-1.1 259740
3 EX-4.1 d854991dex41.htm EX-4.1 73843
4 EX-5.1 d854991dex51.htm EX-5.1 13726
5 EX-5.2 d854991dex52.htm EX-5.2 12834
6 EX-99.1 d854991dex991.htm EX-99.1 9986
7 EX-99.2 d854991dex992.htm EX-99.2 10623
11 GRAPHIC g854991g0618050749230.jpg GRAPHIC 2074
12 GRAPHIC g854991g0618140349027.jpg GRAPHIC 2534
  Complete submission text file 0001193125-24-163498.txt   658109

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA urgn-20240617.xsd EX-101.SCH 2848
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20240617_lab.xml EX-101.LAB 17995
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20240617_pre.xml EX-101.PRE 11260
24 EXTRACTED XBRL INSTANCE DOCUMENT d854991d8k_htm.xml XML 3643
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 241052894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)